Predictive Biosciences tapped veteran diagnostics industry executive Kim Blickenstaff, president and CEO of insulin pump developer Tandem Diabetes Care Inc., for its board of directors.
The Lexington, Mass-based cancer diagnostics developer said Blickenstaff’s expertise will come in handy as it readies to bring a non-invasive molecular diagnostic for bladder cancer to market via a recent acquisition.